DNAJB14 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 9.19739950866472E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.87579999999921E-05 |
Normal-vs-Stage2 |
1.082050E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
7.381600E-03 |
Stage1-vs-Stage2 |
9.995000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
9.600200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
9.564000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.99700003597781E-09 |
Normal-vs-AfricanAmerican |
3.050800E-01 |
Normal-vs-Asian |
4.631500E-02 |
Caucasian-vs-AfricanAmerican |
4.519800E-01 |
Caucasian-vs-Asian |
5.146600E-01 |
AfricanAmerican-vs-Asian |
3.134800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.30339999999618E-05 |
Normal-vs-Female |
3.11220000004386E-06 |
Male-vs-Female |
2.265000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
9.415100E-03 |
Normal-vs-Extreme_Weight |
2.11270000000097E-05 |
Normal-vs-Obese |
9.239900E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.544200E-01 |
Normal_Weight-vs-Obese |
3.416200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
2.848600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.098170E-01 |
Normal-vs-Age(41-60Yrs) |
4.381500E-03 |
Normal-vs-Age(61-80Yrs) |
4.70080000036788E-07 |
Normal-vs-Age(81-100Yrs) |
5.039600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.629000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.669600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.662200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.974200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.653200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.779200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
2.270200E-01 |
Normal-vs-Grade 3 |
7.820500E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.883800E-01 |
Grade 2-vs-Grade 4 |
2.270200E-01 |
Grade 3-vs-Grade 4 |
7.820500E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.3041000000168E-06 |
Normal-vs-N1 |
8.459600E-03 |
N0-vs-N1 |
4.259000E-01 |
|
|